Skip to content

Apotheek Xavier Ameloot: what changed

BE 0872.659.609NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€99,125
2024 · €87,583+€11,542
Equity
€726,691
2024 · €627,567+€99,124
Cash
€5,281
2024 · €21,158-€15,877
Balance sheet total
€1.9m
2024 · €1.7m+€205,020

Largest movements

2024 to 2025
Assets
  • Tangible fixed assets +€151,633

    up €151,633 (+43.3%), from €349,963 to €501,596

    of which Land and buildings: +€147,307

  • Deferred charges and accrued income +€137,614

    new in 2025: €137,614

  • Receivables within one year -€118,739

    down €118,739 (-12.0%), from €985,668 to €866,929

    of which Trade receivables: -€195,688

  • Stocks and contracts +€50,388

    up €50,388 (+14.7%), from €342,433 to €392,821

Equity and liabilities
  • Debts after one year +€272,743

    up €272,743 (+110%), from €248,648 to €521,391

  • Trade debts -€164,917

    down €164,917 (-46.4%), from €355,080 to €190,163

  • Reserves +€99,124

    up €99,124 (+16.5%), from €602,567 to €701,691

  • Other debts -€76,524

    down €76,524 (-31.8%), from €240,588 to €164,064

  • Accrued charges and deferred income +€35,917

    new in 2025: €35,917

Income statement
  • Gross operating margin +€78,973

    up €78,973 (+23.2%), from €340,448 to €419,421

  • Depreciation +€30,362

    up €30,362 (+111%), from €27,450 to €57,812

  • Financial charges +€19,137

    up €19,137 (+89.2%), from €21,443 to €40,580

  • Staff costs +€6,260

    up €6,260 (+3.6%), from €175,878 to €182,138

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €87,583
Gross operating margin +€78,973
Staff costs -€6,260
Depreciation -€30,362
Other operating charges +€187
Other operating items -€13,103
Financial income +€3,507
Financial charges -€19,137
Taxes -€2,262
Result 2025 €99,125
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations -€116,032
Investment -€209,445
Financing +€309,600
Cash 2024 €21,158
Net result for the year +€99,125
Depreciation +€57,812
Stocks and contracts -€50,388
Receivables within one year +€118,739
Deferred charges and accrued income -€137,614
Trade debts -€164,917
Tax, wage and social debts +€1,818
Other debts -€76,524
Accrued charges and deferred income +€35,917
Investment in fixed assets (net) -€209,445
Debts after one year +€272,743
Current portion of long-term debt +€29,494
Short-term financial debts +€7,365
Contributions, distributions and other -€1
Cash 2025 €5,281
brings cash intakes cash out
Every line side by side 48 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,706,721 €1,911,741 +€205,020 +12.0%
Fixed assets 21/28 €357,463 €509,096 +€151,633 +42.4%
Tangible fixed assets 22/27 €349,963 €501,596 +€151,633 +43.3%
Land and buildings 22 - €147,307 +€147,307
Plant, machinery and equipment 23 €224,636 €203,203 -€21,433 -9.5%
Furniture and vehicles 24 €125,328 €151,086 +€25,758 +20.6%
Financial fixed assets 28 €7,500 €7,500 = 0.0%
Current assets 29/58 €1,349,258 €1,402,645 +€53,387 +4.0%
Stocks and contracts in progress 3 €342,433 €392,821 +€50,388 +14.7%
Stocks 30/36 €342,433 €392,821 +€50,388 +14.7%
Amounts receivable within one year 40/41 €985,668 €866,929 -€118,739 -12.0%
Trade receivables 40 €303,011 €107,323 -€195,688 -64.6%
Other amounts receivable 41 €682,657 €759,606 +€76,949 +11.3%
Cash at bank and in hand 54/58 €21,158 €5,281 -€15,877 -75.0%
Deferred charges and accrued income 490/1 - €137,614 +€137,614
Total equity and liabilities 10/49 €1,706,721 €1,911,741 +€205,020 +12.0%
Equity 10/15 €627,567 €726,691 +€99,124 +15.8%
Contributions 10/11 €25,000 €25,000 = 0.0%
Reserves 13 €602,567 €701,691 +€99,124 +16.5%
Distributable reserves 133 €602,567 €701,691 +€99,124 +16.5%
Amounts payable 17/49 €1,079,154 €1,185,050 +€105,896 +9.8%
Amounts payable after more than one year 17 €248,648 €521,391 +€272,743 +110%
Financial debts 170/4 €248,648 €521,391 +€272,743 +110%
Amounts payable within one year 42/48 €830,506 €627,742 -€202,764 -24.4%
Current portion of amounts payable after more than one year 42 €25,596 €55,090 +€29,494 +115%
Financial debts 43 €176,268 €183,633 +€7,365 +4.2%
Credit institutions 430/8 €176,268 €183,633 +€7,365 +4.2%
Trade debts 44 €355,080 €190,163 -€164,917 -46.4%
Suppliers 440/4 €355,080 €190,163 -€164,917 -46.4%
Taxes, remuneration and social security 45 €32,974 €34,792 +€1,818 +5.5%
Taxes 450/3 €6,501 €8,570 +€2,069 +31.8%
Remuneration and social security 454/9 €26,473 €26,222 -€251 -0.9%
Other amounts payable 47/48 €240,588 €164,064 -€76,524 -31.8%
Accrued charges and deferred income 492/3 - €35,917 +€35,917
Remuneration, social security and pensions 62 €175,878 €182,138 +€6,260 +3.6%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €27,450 €57,812 +€30,362 +111%
Other operating charges 640/8 €1,787 €1,600 -€187 -10.4%
Non-recurring operating charges 66A - €13,103 +€13,103
Gross operating margin 9900 €340,448 €419,421 +€78,973 +23.2%
Operating profit (loss) 9901 €135,334 €164,768 +€29,434 +21.7%
Financial income 75/76B - €3,507 +€3,507
Recurring financial income 75 - €3,507 +€3,507
Financial charges 65/66B €21,443 €40,580 +€19,137 +89.2%
Recurring financial charges 65 €21,443 €40,580 +€19,137 +89.2%
Profit (loss) for the period before taxes 9903 €113,891 €127,695 +€13,804 +12.1%
Income taxes 67/77 €26,308 €28,570 +€2,262 +8.6%
Profit (loss) for the period 9904 €87,583 €99,125 +€11,542 +13.2%
Profit (loss) for the period to be appropriated 9905 €87,583 €99,125 +€11,542 +13.2%

Value

latest balance sheet 30-09-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€887,438 to €1.1m

Midpoint €974,787 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Adjusted equity €726,691
Capitalised earnings €1.0m to €1.5m
Indication €887,438 to €1.1m

Adjusted equity

balance sheet 30-09-2025
Equity (10/15)
€726,691
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€726,691

Capitalised earnings

net result for the year (9904)
2025
€99,125
excluding non-recurring income and charges
€112,228
2024
€87,583
2023
€240,425
2022
€104,819
2021
€99,027
Average result, excluding non-recurring income and charges
€146,746
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€1.0m / €1.2m / €1.5m

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 30 September 2024 and 30 September 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 13 November 2026 via checked.be.